GetTopicDetailResponse(id=517c8419471, topicName=胸腺素α1, introduction=胸腺素α1, content=null, image=null, comments=1, allHits=658, url=https://h5.medsci.cn/topic?id=84194, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=48751, tagList=[TagDto(tagId=48751, tagName=胸腺素α1)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2271833, encodeId=4cdd22e1833e4, content=<a href='/topic/show?id=517c8419471' target=_blank style='color:#2F92EE;'>#胸腺素α1#</a>是由<a href='/topic/show?id=451a8418304' target=_blank style='color:#2F92EE;'>#胸腺#</a>分泌的天然<a href='/topic/show?id=fd6f4340017' target=_blank style='color:#2F92EE;'>#多肽#</a>，已知其能改善<a href='/topic/show?id=ae97180090b' target=_blank style='color:#2F92EE;'>#T細(xì)胞#</a>功能、增強(qiáng)抗感染免疫應(yīng)答、調(diào)節(jié)<a href='/topic/show?id=554e61989e7' target=_blank style='color:#2F92EE;'>#樹突狀細(xì)胞#</a>活性等。小規(guī)模臨床研究和meta分析提示胸腺素α1可能降低<a href='/topic/show?id=a63592333b0' target=_blank style='color:#2F92EE;'>#敗血癥#</a>患者的短期死亡率，但由于研究樣本量小和方法學(xué)限制，尚缺乏高質(zhì)量的Ⅲ期臨床試驗(yàn)數(shù)據(jù)支持。<a href='/topic/show?id=7a2f851921d' target=_blank style='color:#2F92EE;'>#膿毒癥#</a>, objectTitle=BMJ：胸腺素α1治療成人敗血癥的療效與安全性——一項(xiàng)多中心、雙盲、隨機(jī)、安慰劑對(duì)照Ⅲ期臨床試驗(yàn), objectType=article, longId=885048, objectId=00ba88504857, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250214/1739513070292_8538692.jpg, objectUrl=/article/show_article.do?id=00ba88504857, replyNumber=0, likeNumber=26, createdTime=2025-07-03, rootId=0, userName=俠膽醫(yī)心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=00ba88504857, moduleTitle=BMJ：胸腺素α1治療成人敗血癥的療效與安全性——一項(xiàng)多中心、雙盲、隨機(jī)、安慰劑對(duì)照Ⅲ期臨床試驗(yàn), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=00ba88504857)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2271700, encodeId=a75a22e1700aa, content=<a href='/topic/show?id=a63592333b0' target=_blank style='color:#2F92EE;'>#敗血癥#</a> <a href='/topic/show?id=517c8419471' target=_blank style='color:#2F92EE;'>#胸腺素α1#</a>, objectTitle=BMJ：胸腺素α1治療成人敗血癥的療效與安全性——一項(xiàng)多中心、雙盲、隨機(jī)、安慰劑對(duì)照Ⅲ期臨床試驗(yàn), objectType=article, longId=885048, objectId=00ba88504857, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250214/1739513070292_8538692.jpg, objectUrl=/article/show_article.do?id=00ba88504857, replyNumber=0, likeNumber=35, createdTime=2025-07-02, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=00ba88504857, moduleTitle=BMJ：胸腺素α1治療成人敗血癥的療效與安全性——一項(xiàng)多中心、雙盲、隨機(jī)、安慰劑對(duì)照Ⅲ期臨床試驗(yàn), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=00ba88504857)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯話題小助手
2020-05-29
